Convoke

We benchmarked the comprehensiveness of our free pipeline database against a leading paid incumbent database -- our asset coverage is 28% higher overall. If you're paying for a pipeline database and not happy with the data quality try ours out at platform.convoke.bio

Much effort has gone into improving and benchmarking LLM performance on drug discovery, but what about commercial, development, or operational work?

In our new biopharma knowledge work benchmark, we find that OpenAI models lead with strong performance on a diverse set of tasks

We’ve extended the functionality of our free program tracker with the ability to create agents that monitor drugs, targets, and organizations of interest and report back on findings automatically. Try it out at platform.convoke.bio, new users get some starter credits

We weren’t happy with the existing drug pipeline and catalyst databases, so we built a new one designed to be easy for both humans and LLMs to use.

We’re making it freely available today as a community resource. The sign-up link and blog post are in the thread below.

Today we're publishing our index of unmet needs in human disease: 2443 indications scored and ranked on burden of disease, prevalence, pipeline activity, and treatment burden. We hope this will help drug developers identify overlooked medical problems

convoke.bio/blog/introduci…